Blood and bleeding tissue

Blood and bleeding tissue refers to the physiological system comprising blood cells, plasma, and the vascular components involved in hemostasis and circulation (StatPearls, 2023). It is not a single molecular target but rather a complex biological environment containing numerous therapeutic targets such as coagulation factors, platelets, and endothelial receptors (NIH, 2022). In the context of pharmacology, interventions in this area are primarily focused on managing disorders of hemostasis, including thrombosis and various bleeding diatheses (PubMed, 2021). Drugs interacting with this system include anticoagulants, antiplatelets, and fibrinolytic agents, which work by altering the balance between clot formation and dissolution (PubChem, 2024). Because it encompasses a wide array of proteins and cell types, it is considered an incorrectly specified target for molecular-level drug discovery and should be replaced with specific molecular entities like Thrombin or Factor Xa.

Other names

Hematic systemCirculatory systemHemorrhagic tissueHematologic system

Drugs associated with this system typically modulate the coagulation cascade, inhibit platelet aggregation, or prevent fibrin degradation to manage bleeding or clotting disorders.